Operating Income: The income after operating expenses.
Legend Biotech Corporation Sponsored ADR (LEGN) had Operating Income of $-23.04M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$306.46M |
|
$-30.82M |
|
$123.46M |
|
$183.00M |
|
$329.50M |
|
|
Operating Income |
$-23.04M |
$3.44M |
|
$-19.60M |
|
$-20.57M |
|
$-30.82M |
|
$-30.82M |
|
$-30.82M |
|
$-31.77M |
|
$-23.04M |
|
$-11.07M |
|
184.32M |
|
184.32M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$1.25B |
|
$116.30M |
|
$486.60M |
|
$1.73B |
|
$636.40M |
|
-- |
|
$95.20M |
|
$731.60M |
|
$1.00B |
|
$1.00B |
|
$1.00B |
|
184.94M |
|
| Cash Flow Statement Financials | |
$-100.20M |
|
$709.60M |
|
$-0.30M |
|
$286.70M |
|
$901.90M |
|
$615.20M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.96 |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
59.71% |
|
-7.52% |
|
-7.52% |
|
-- |
|
-6.40% |
|
-10.06% |
|
$-128.80M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
3.86 |
|
23.39 |
|
3.85 |
|
-3.08% |
|
-3.08% |
|
-1.78% |
|
-3.08% |
|
$5.42 |
|
$-0.70 |
|
$-0.54 |
|